Skip to content
2000
Volume 13, Issue 2
  • ISSN: 1570-1611
  • E-ISSN: 1875-6212

Abstract

Dyslipidemia represents one of the major risk factors for atherosclerosis affecting the arteries of large and medium caliber and consequently causing ischemia in the brain, heart, or legs. Coronary artery disease and cerebral stroke represent the major causes of morbidity and mortality among the elderly and middle aged subjects. The change of lifestyle can reduce the risk of cardiovascular disease but available drug therapy (in particular statins, inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase) is effective in modifying hyperlipidemia and consequently reducing cardiovascular events. The hypolipemic drugs can prevent, slow the progression and sometimes determine the regression of atherosclerotic plaques, therefore significantly reducing the clinical complications of atherosclerotic cardiovascular disease. In this review, we want to point out the role of the different lipoproteins, such as triglycerides, HDL-C, LDLC, Lp(a), in the pathogenesis of stroke and the role of statins in reducing both lipid fractions and stroke risk.

Loading

Article metrics loading...

/content/journals/cvp/10.2174/15701611113116660166
2015-01-01
2025-05-23
Loading full text...

Full text loading...

/content/journals/cvp/10.2174/15701611113116660166
Loading

  • Article Type:
    Research Article
Keyword(s): Cardiovascular risk; dyslipidemias; lipid lowering therapy; lipoproteins; statins; stroke
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test